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Introduction: Mesenchymal stem cells (MSCs) reside in a variety of tissues and provide a stromal role in regulating
progenitor cell function. Current studies focus on identifying the specific factors in the niche that can alter the MSC
secretome, ultimately determining the effectiveness and timing of tissue repair. The purpose of the present study
was to evaluate the extent to which substrate and mechanical strain simultaneously regulate MSC quantity, gene
expression, and secretome.
Methods: MSCs (Sca-1+CD45−) isolated from murine skeletal muscle (muscle-derived MSCs, or mMSCs) via
fluorescence-activated cell sorting were seeded onto laminin (LAM)- or collagen type 1 (COL)-coated membranes
and exposed to a single bout of mechanical strain (10%, 1 Hz, 5 hours).
Results: mMSC proliferation was not directly affected by substrate or strain; however, gene expression of growth
and inflammatory factors and extracellular matrix (ECM) proteins was downregulated in mMSCs grown on COL in a
manner independent of strain. Focal adhesion kinase (FAK) may be involved in substrate regulation of mMSC
secretome as FAK phosphorylation was significantly elevated 24 hours post-strain in mMSCs plated on LAM but not
COL (P <0.05). Conditioned media (CM) from mMSCs exposed to both LAM and strain increased myoblast quantity
5.6-fold 24 hours post-treatment compared with myoblasts treated with serum-free media (P <0.05). This response
was delayed in myoblasts treated with CM from mMSCs grown on COL.
Conclusions: Here, we demonstrate that exposure to COL, the primary ECM component associated with tissue
fibrosis, downregulates genes associated with growth and inflammation in mMSCs and delays the ability for mMSCs
to stimulate myoblast proliferation.Introduction
Mesenchymal stem/stromal cells (MSCs) are a pluripotent
population of cells that reside in a variety of tissues
throughout the body. These cells are defined by their cap-
acity for multi-lineage differentiation, including chondro-
genesis, osteogenesis, and adipogenesis [1]. Owing to their
multi-lineage potential, immune-privileged nature, relative
ease of isolation, and ability to be expanded in culture,
MSCs have received much attention for their potential use
in cell therapy [2]. Recently, it was suggested that the* Correspondence: mboppart@illinois.edu
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repair is indirect via secretion of factors that stimulate na-
tive tissue repair processes or tissue-resident stem cells
[3]. It was suggested that the MSC secretome is strongly
regulated by the local microenvironment [3]. For example,
hypoxia can stimulate MSC secretion of vascular endothe-
lial growth factor (VEGF) and interleukin-6 (IL-6) [4], and
factors released from MSCs can reverse degenerative
processes in a variety of tissues, including heart [3], brain
[5], the hematopoietic system [6], and skeletal muscle [7].
For these reasons, MSCs provide an exciting cell popula-
tion for therapy, and defining cell culture conditions
that allow optimal MSC expansion and function prior tol Ltd. This is an Open Access article distributed under the terms of the Creative
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their efficacy.
Mesenchymal progenitor cells have been identified in
skeletal muscle that directly or indirectly contributes to
repair in response to injury [7]. These multi-potent stem
cells have been isolated by using unique cell surface
markers and thus classified as side population cells [8,9],
pericytes [10], muscle-derived stem cells [11], muscle-
derived MSCs (mMSCs) [12,13], fibro/adipogenic pro-
genitors [14], and PW1+ interstitial cells [15], and some
degree of overlap likely exists between these cell popula-
tions. Whereas some of these cells can become myogenic,
the majority have limited capacity for myogenic differenti-
ation and are primed to secrete factors essential for indirect
repair of skeletal muscle. We recently defined a population
of MSCs, identified by expression of stem cell antigen 1
(Sca-1+) and lack of expression of a hematopoietic cell sur-
face marker (CD45−), that is capable of osteogenic, chon-
drogenic, and adipogenic differentiation and accumulate in
skeletal muscle (mMSCs) after eccentric exercise in an α7-
integrin-dependent manner [12]. We also recently demon-
strated that Sca-1+CD45− mMSCs are involved in muscle
repair after injury [12], perhaps through secretion of para-
crine factors [16]. Currently, minimal information exists re-
garding the cues in the environment that regulate MSC
paracrine factor synthesis and secretion [16].
The MSC niche is complex, and composition of the
MSC niche in each tissue type is defined by a unique com-
bination of growth/inflammatory factors, extracellular
matrix (ECM) components, other cell types, and topog-
raphy [17]. In skeletal muscle, the extracellular environ-
ment consists of a variety of matrix proteins, including
but not limited to collagen type 1 (COL) and laminin
(LAM) [18]. COL is the primary collagen isoform in the
perimysium and accumulates during muscle fibrosis [18]
that accompanies disease, injury, and aging [19,20]. The
resulting fibrosis causes dysregulation of muscle-derived
stem cells which may be a major factor inhibiting muscle
regeneration and repair [19,21]. Because the musculoskel-
etal system is highly dynamic and responsive to move-
ment, mechanical strain may largely intersect and alter
the MSC response to COL or LAM or both [22]. Some in-
formation exists regarding MSC mechanosensory signal-
ing and lineage specification. For example, MSCs derived
from bone marrow are directed toward an osteogenic fate
when subjected to multiple bouts of biaxial strain [23-25]
and this may be dependent on the activation of focal adhe-
sion kinase (FAK) [10]. In addition, mMSCs secrete a var-
iety of growth factors in response to biaxial strain in the
presence of LAM [16]. However, the full extent to which
MSCs residing in skeletal muscle are responsive to mech-
anical strain in the context of substrate has yet to be de-
termined. This information is essential for elucidating a
role for mMSCs in whole tissue health and designing cell-based therapies that can most effectively combat skeletal
muscle disease and disabilities.
The purpose of the present investigation was to
characterize the mMSC response to mechanical strain in
the context of substrate. We hypothesized that mechanical
strain would increase mMSC quantity or gene expression of
factors that would promote skeletal muscle regeneration (or
both) while exposure to COL would inhibit this response.
Materials and methods
α7 Integrin transgenic mice
Mice created to overexpress α7 integrin specifically in
skeletal muscle (MCK-α7BX2), referred to as α7Tg mice,
were produced and bred in-house [26]. Overexpression of
α7 integrin BX2 subunit was determined by polymerase
chain reaction (PCR) analysis (primers: MCK1, 5′-CA
AGCTGCACGCCTGGGTCC-3′ and AATII, 5′-GGCAC
CCATGACGTCCAGATTGAAG-3′) as previously de-
scribed [27]. Mice were maintained on a 12-hour light/
dark cycle and were provided food and water ad libitum.
All protocols were approved by the Institutional Animal
Care and Use Committee of the University of Illinois at
Urbana-Champaign.
Muscle-derived mesenchymal stem/stromal cell isolation
mMSCs were isolated as previously described [12,16].
Briefly, 5- to 6-week-old α7Tg mice were sacrificed by car-
bon dioxide (CO2) asphyxiation, and gastrocnemius-
soleus complexes were resected and minced into a fine
paste. Minced muscle tissue was enzymatically digested in
phosphate-buffered saline containing 0.2% collagenase
Type 2 (Worthington, Biochemical Corp., Lakewood, NJ,
USA), 60 U/mL DNase (Sigma-Aldrich, St. Louis, MO,
USA), and 2.5 mM Ca2Cl2 at 37°C for 45 minutes. Muscle
slurries were mixed with Hank’s Balanced Salt Solution
containing 20% fetal bovine serum (FBS) and 0.1% penicil-
lin/streptomycin to stop enzymatic digestion and were
passed through a 70-μm filter. Cells were blocked in Fc-
receptor block (CD16/CD32; eBioscience, San Diego, CA,
USA) for 10 minutes on ice and then stained with Sca-1-
PE and CD45-APC (eBioscience). After washing, cells
were passed through a 40-μm filter prior to sorting on an
iCyt Reflection System (Champaign, IL, USA). Unstained
and single-stained controls were used to establish gates.
Sorted cells were seeded onto plastic cell culture dishes
at a density of 2.5 × 104 cells per cm2 in growth media
(Dulbecco’s modified Eagle’s medium [DMEM]/10% FBS/
5 μg/mL gentamicin). After 3 days of culture at 37°C and
5% CO2, non-adherent cells were removed.
In vitro strain protocol and assessment of muscle-derived
mesenchymal stem/stromal cell quantity
Passage-1 or -2 mMSCs were seeded at equal density on
either laminin (YIGSR; LAM)- or collagen type 1 (COL)-








Laminin α1 CAGCGCCAATGCTACCTGT GGATTCGTACTGTTACCGTCACA
Laminin α2 TCCCAAGCGCATCAACAGAG CAGTACATCTCGGGTCCTTTTTC
GM-CSF ACCACCTATGCGGATTTCAT TCATTACGCAGGCACAAAAG
HGF ATGTGGGGGACCAAACTTCTG GGATGGCGACATGAAGCAG
Table 2 Primers and probes for Taqman analysis
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McKeesport, PA, USA). Cells were allowed to adhere and
expand for 12 to 72 hours in growth media until they
were approximately 80% confluent. Cells were strained
according to our previously published protocol that has
been shown to alter myogenic gene expression in
mMSCs [12] and the mMSC secretome in a manner that
supported arteriogenesis [16]. Briefly, cells were ex-
posed to 10% biaxial strain at a frequency of 1 Hz for
5 hours using an FX-4000 Flexercell Tension System
(Flexcell International Corporation). Non-strained cells
were maintained in the same manner but not exposed
to strain. Four experimental conditions were tested:
(1) LAM/No Strain (NSL), (2) LAM/Strain (SL), (3)
COL/No Strain (NSC), and (4) COL/Strain (SC). For
conditioned media (CM) experiments, growth media
were replaced with serum-free media (SFM) (DMEM/
5 μg/mL gentamicin) prior to the strain protocol, col-
lected at 24 hours after the initiation of strain, and
stored at −80°C until use. mMSCs were trypsinized and
quantified by using a hemocytometer 48 hours after
strain. All images were obtained by using a Zeiss Axio-
Cam digital camera and Axiovision software at 20×
magnification (Zeiss, Thornwood, NY, USA).
Gene expression analysis
Three hours after stretch, mMSCs were collected by cell
scraping and were centrifuged, and the pellet was frozen
at −80°C. Isolation of total RNA was conducted by using
the PureLink RNA mini kit (Ambion, a brand of Life
Technologies, Carlsbad, CA, USA) in accordance with the
instructions of the manufacturer. The RNA was quantified
spectrophotometrically via the Synergy H1 Hybrid Multi-
Mode Microplate Reader (Biotek, Winooski, VT, USA).
Reverse transcription of RNA to cDNA was completed by
using a High Capacity cDNA RT Kit (Applied Biosystems,
Grand Island, NY). Quantitative real-time polymerase chain
reaction (qPCR) was performed either by using SYBR
Green/Rox master mix (SuperArray Biosciences, Frederick,
MD, USA) with previously published primer sequences or
by using pre-designed Taqman primers and probes validated
by Applied Biosystems (Foster City, CA, USA) (Tables 1
and 2). qPCR was performed by using the ABI 7900HT
Fast Real Time PCR System (Applied Biosystems) under
standard conditions and analyzed by using SDS 2.4 Software
(Applied Biosystems). Dissociation curve analysis was per-
formed for SYBR Green reactions to confirm primer specifi-
city. Changes in gene expression relative to LAM/NS were
calculated by using the 2−ΔΔCT method [28] with GAPDH
or L32 as housekeeping genes.
Western blotting
Proteins were extracted directly from cell culture plates
in ice-cold lysis buffer consisting of 50 mM Tris-HCl,150 nM NaCl, 1 mM PMSF, 1% NP-40, 0.5% sodium deox-
ycholate, and 0.1% SDS with protease and phosphatase in-
hibitors (Roche, Indianapolis, IN, USA). Samples were
incubated in lysis buffer for 45 minutes at 4°C, and super-
natants were collected for determination of protein con-
centrations by Bradford assay. Equal amounts of protein,
as confirmed by ponceau S, in 4X Laemlli buffer were sep-
arated by SDS-PAGE and transferred to nitrocellulose
membranes. After blocking with 5% non-fat dry milk or
5% bovine serum albumin, membranes were incubated in
the following primary antibodies: phospho-mTOR
(Ser2448), mTOR, p70 S6 Kinase, phospho-p70 S6 Kinase
(Thr389), phospho-FAK (Tyr 397), phospho-NF-κB p65
(Ser 536) (Cell Signaling Technology, Boston, MA, USA),
FAK (Santa Cruz Biotechnology, Santa Cruz, CA, USA), or
NF-κB p65 (eBioscience) overnight at 4°C. Horseradish
peroxidase-conjugated anti-rabbit secondary antibody
(Jackson ImmunoResearch Laboratories, Inc., West Grove,
PA, USA) was applied for 1 hour at room temperature.
Proteins were detected with SuperSignal West Pico Chemi-
luminescent Substrate (Pierce, Rockford, IL, USA) by using
a Bio-Rad ChemiDoc XRS system (Bio-Rad Laboratories,
Hercules, CA, USA). After detection of phosphorylated
proteins, membranes were stripped with Restore Western
Blot Stripping Buffer (Thermo Fisher Scientific, Waltham,
MA, USA) prior to probing for total protein. Protein
content was quantified by using Quantity One software
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samples that did not give values above background were
omitted from analysis. For each protein, phosphorylated
protein content was expressed relative to total protein con-
tent and normalized to the average of LAM/NS to obtain a
fold change.
Myoblast and myotube culture experiments
Littermates of α7Tg mice that did not overexpress the
transgene were used for primary myoblast isolation.
Myoblasts were isolated from neonatal mice by using a
sequential plating technique as previously described
[29], except plates were coated with gelatin instead of
collagen as we have found that gelatin increases the effi-
ciency of isolation. Primary myoblasts and C2C12 cells
(ATCC, Manassas, VA, USA) were maintained at 37°C in
5% CO2, expanded in growth media (DMEM/20% FBS/
1% penicillin-streptomycin), and differentiated in differ-
entiation media (DMEM/2% horse serum/1% penicillin-
streptomycin). For CM experiments, CM was quickly
thawed, centrifuged at 400 g for 5 minutes at 4°C to re-
move any remaining cells, and added to primary myo-
blasts seeded at equal density or myotubes formed from
C2C12 myoblasts. Myoblasts or myotubes treated with
SFM and either growth or differentiation media served
as negative and positive controls. Myotubes were har-
vested 3 hours after treatment with CM for evaluation of
hypertrophic signaling. Myoblast quantity was analyzed
at 24 and 48 hours post-treatment with CM via the
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazo-
lium bromide; thiazolyl blue)-based Cell Growth Deter-
mination Kit (Sigma-Aldrich) in accordance with the
instructions of the manufacturer, and values were
expressed as a fold change relative to myoblasts treated
with SFM for the same amount of time.
Statistical analysis
Data are presented as mean ± standard error of the mean.
Two-factor analysis of variance (substrate × strain) was
conducted followed by Tukey post hoc test if a significant
difference was detected. All statistical analyses were
conducted by using SigmaPlot 12.5 (Systat Software,
Inc., Chicago, IL, USA). Differences were considered
significant at a P value of less than 0.05.
Results
Exposure to different substrates or strain does not alter
muscle-derived mesenchymal stem/stromal cell quantity
but alters myogenic gene expression
mMSCs displayed their characteristic fibroblast-like ap-
pearance with numerous projections spreading out from
the cell body on both COL and LAM (Figure 1A). Nei-
ther substrate nor strain influenced the quantity of
mMSCs at 48 hours (Figure 1B). Gene expressions ofthe myogenic regulatory factors (MRFs) Myf5 (P <0.01),
MyoD (P <0.01), and Myogenin (P <0.05) were all sig-
nificantly downregulated in mMSCs grown on COL
(Figure 1C-E). The myoblast-specific transcription factor
Pax7 was not reliably detected in any samples analyzed
(data not shown).
Muscle-derived mesenchymal stem/stromal cell gene
expression is downregulated on collagen 1
Growth factor gene expression was generally downregu-
lated in mMSCs grown on COL with a significant decrease
in the expression of VEGFa (Figure 2A; P <0.01), a trend to-
ward a decrease in expression of granulocyte-macrophage
colony-stimulating factor (GM-CSF) (Figure 2B; P = 0.087),
and no change in hepatocyte growth factor (HGF) expres-
sion (Figure 2C). Similarly, gene expression of the inflam-
matory cytokines IL-6 (P <0.01), transforming growth
factor-beta 1 (TGF-β1) (P <0.05), and tumor necrosis
factor-alpha (TNF-α) (P <0.01) was significantly decreased
in mMSCs grown on COL (Figure 2D-F). The expression
of growth or inflammatory factors was not influenced by
strain (Figure 2A-F). Laminin α1 gene expression was sig-
nificantly decreased (Figure 3A; P <0.01) in mMSCs on
COL, whereas laminin α2 was not altered (Figure 3B).
There was a strong trend for an interaction (P = 0.050) be-
tween substrate and strain for collagen 1α1 (Figure 3C)
with no differences in expression of collagen 1α2.
Substrate and stretch alter the activation of focal
adhesion kinase but not nuclear factor-kappa B
FAK is an intracellular signaling molecule that responds
to various factors in the cellular microenvironment and
may facilitate the process of mechanotransduction [30].
Levels of phosphorylated FAK were not altered on either
substrate 3 hours post-strain (Figure 4A). At 24 hours
post-strain, FAK phosphorylation was significantly in-
creased in mMSCs strained on LAM (Figure 4B; P <0.05),
whereas total levels of FAK were increased on COL (data
not shown). Neither NF-κB phosphorylation nor levels of
total protein were altered by substrate or strain at either
time point (Figure 4C-D).
The muscle-derived mesenchymal stem/stromal cell
secretome increases myoblast quantity but does not
influence hypertrophic signaling in myotubes
CM were collected from mMSCs not strained on
LAM (NSL), strained on LAM (SL), not strained on
COL (NSC), and strained on COL (SC) and used to
treat C2C12-derived myotubes or primary myoblasts.
CM from SL increased the quantity of primary myo-
blasts after 24 hours of treatment as compared with
NSL and SC (Figure 5A; P <0.01 and P <0.001, respect-
ively). After 48 hours of treatment, primary myoblasts






Figure 1 Muscle-derived mesenchymal stem/stromal cell (mMSC) appearance, proliferation, and myogenic gene expression. mMSCs
were plated on laminin (LAM) or collagen (COL) and were either exposed to mechanical strain or remained unstrained. Representative images of
mMSCs exposed to the various substrates (A). mMSC quantity as determined by hemocytometer 48 hours post-strain with non-strained cells
serving as controls (n = 6 per group) (B). Gene expression of the myogenic regulatory factors Myf5 (C), MyoD (D), and Myogenin (E) 3 hours
post-strain (n = 3 per group). Pax7 mRNA was not reliably detected in any group. Fold change is relative to LAM no strain. Data are presented as
mean ± standard error of the mean. **P <0.01 versus LAM (main effect for substrate).
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main effect for COL) and a strong trend was observed
for increased quantity of primary myoblasts when ex-
posed to CM from strained mMSCs (P = 0.050 for
strain). In myotubes, activation of two signaling mole-
cules involved in the initiation of protein synthesis,
mTOR and p70 S6 Kinase, was not altered at 3 hours
when exposed to CM from any of the above conditions
(Figure 6A and B).Discussion
In the present investigation, we demonstrate that
mMSCs are responsive to different substrates in their
environment and, to a lesser extent, mechanical strain.
COL, an ECM protein that accumulates in fibrotic con-
ditions, resulted in decreased expression of a wide var-
iety of genes, including MRFs, growth factors, cytokines,
and ECM proteins in mMSCs. These results suggest




Figure 2 Muscle-derived mesenchymal stem/stromal cell (mMSC) growth and inflammatory factor gene expression. mMSCs were plated
on laminin (LAM) or collagen (COL) and were either exposed to mechanical strain or remained unstrained. mRNA for vascular endothelial growth
factor a (VEGFa) (A), granulocyte-macrophage colony-stimulating factor (GM-CSF) (B), hepatocyte growth factor (HGF) (C), interleukin-6
(IL-6) (D), transforming growth factor-beta 1 (TGF-β1) (E), and tumor necrosis factor-alpha (TNF-α) (F) was analyzed 3 hours after strain and
expressed relative to LAM no strain (n = 3 per group). Data are presented as mean ± standard error of the mean. *P <0.05; **P <0.01 versus LAM.
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their production of growth and inflammatory factors in-
volved acutely in muscle repair or chronically in muscle
degeneration. Our CM experiments demonstrated that
media from mMSCs strained on LAM enhanced myo-
blast proliferation at 24 hours while this response was
delayed to 48 hours in myoblasts treated with CM from
mMSCs grown on COL. Overall, these data suggest that
collagen accumulation in fibrotic conditions may impair
the myogenic response by inhibiting mMSC function.
mMSCs exist in limited quantities in vivo; therefore,
identifying factors that promote expansion or enhance
their function would increase the clinical utility of these
cells. In agreement with previous findings in primary
myoblasts [31], we did not observe any differences in
mMSC quantity when grown on LAM or COL. Further-
more, strain did not enhance mMSC proliferation on
either substrate. mMSCs may contribute to muscleregeneration or repair by direct differentiation or fusion
with existing muscle fibers or indirectly via the promo-
tion of satellite cell activation and differentiation [32].
Expression of the MRFs Myf5, MyoD, and myogenin
was downregulated on COL, suggesting that direct dif-
ferentiation toward the myogenic lineage was sup-
pressed. This is in agreement with a previous study that
examined the effects of different substrates on expres-
sion of Myf5 as well as myotube formation of a mixed
population of primary myoblasts and demonstrated an
increase in both of these parameters in cells plated on
laminin [31]. Furthermore, it has been suggested that
osteogenic differentiation of MSCs is promoted on colla-
gen 1 [33,34], supporting the notion that COL inhibits
myogenic differentiation. Pax7 expression was also not
reliably detected in any group and this is in agreement
with a previous study demonstrating low Pax7 expres-
sion in MSCs [35] and with a previous study from our
A B
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Figure 3 Muscle-derived mesenchymal stem/stromal cell (mMSC) extracellular matrix gene expression. mMSCs were plated on laminin
(LAM) or collagen (COL) and were either exposed to mechanical strain or remained unstrained. mRNA for laminin α1 (A), laminin α2 (B), collagen
1α1 (C), and collagen 1α2 (D) was analyzed 3 hours after strain and expressed relative to LAM no strain (n = 3 per group). Data are presented as
mean ± standard error of the mean. **P <0.01 versus LAM.
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tains the expression of genes required for myogenesis,
while COL downregulates these genes and promotes dif-
ferentiation along other lineages. The pro-myogenic re-
sponse on LAM may be related to VEGF signaling as
inhibition of VEGF induction in response to mechanical
strain decreased the myogenic potential of muscle-derived
stem cells (MDSCs) [36], and VEGF expression was sig-
nificantly downregulated in mMSCs on COL.
Similar to expression of the MRFs and VEGF, gene ex-
pression of several inflammatory factors was downregu-
lated on COL. The effects of inflammatory factors on
myogenesis are complex with chronic and acute expo-
sures having differential effects. The role of IL-6 on
myogenesis has been extensively evaluated with ablation
of IL-6 linked to impaired muscle hypertrophy [37], and
myoblasts treated with IL-6 in vitro displayed increased
differentiation [38]. In addition, IL-6 localizes to human
satellite cells from young individuals acutely following
eccentric damage [39,40], while this response is dysfunc-
tional with age and may contribute to decreased muscle
repair [41]. Acutely, increases in IL-6 and TNF-α can
promote myogenesis as TNF-α increased satellite cell
proliferation in vivo and in vitro [42]. The pattern of
TNF-α expression mirrors that of IL-6, suggesting
that these two factors are similarly regulated. On the
other hand, chronic exposure to inflammatory cytokines,including IL-6 and TNF-α, has been shown to have det-
rimental effects on myogenesis [43]. Elevated systemic
levels of IL-6 have been associated with muscle wasting
in cancer [44] and aging [45]. The present study indi-
cates that mMSCs are a rich source of paracrine factors
and that expression of these factors is downregulated on
COL. Downregulation of inflammatory factor production
on COL may be a protective mechanism to inhibit
chronic upregulation of these factors in fibrotic environ-
ments that would further contribute to muscle wasting.
Further support for this notion is seen in the trend for a
decrease (P = 0.087) in GM-CSF expression in mMSCs
on COL. GM-CSF is involved in the initial repair re-
sponse of skeletal muscle to injury or mechanical strain
through the recruitment of inflammatory cells [46]. If
mMSCs recognize COL as a signal for fibrosis or a
repaired wound, then decreased recruitment of inflam-
matory mediators would be a beneficial response for
inhibiting propagation of the inflammatory signal.
Aside from altering the paracrine factor composition
within the muscle microenvironment, mMSCs may re-
structure the ECM. Differential expression of laminin α1
and collagen 1α1 was observed in mMSCs plated on dif-
ferent substrates. Laminin α1, a developmentally regu-
lated, critical component of the laminin trimer [47], was
downregulated in mMSCs exposed to COL. Laminin-
α1β1γ1 (LM-111) has previously been used as an effective
Figure 4 Signaling in muscle-derived mesenchymal stem/stromal cell (mMSCs). mMSCs were plated on laminin (LAM) or collagen (COL)
and were either exposed to mechanical strain or remained unstrained. mMSCs were harvested and activation of focal adhesion kinase (FAK) was
determined at 3 hours (A) and 24 hours (B) post-strain. Activation of nuclear factor-kappa B (NF-κB) was also analyzed at 3 hours (C) and 24 hours
(D) post-strain. Representative images are shown above each respective blot. Data are presented as mean ± standard error of the mean. *P <0.05
versus No Strain/LAM. AU, arbitrary units.
De Lisio et al. Stem Cell Research & Therapy 2014, 5:74 Page 8 of 12
http://stemcellres.com/content/5/3/74therapy in pre-clinical models for the treatment of muscu-
lar dystrophies [48-50], indicating that LAM may improve
the muscle microenvironment and increase muscle repair
in pathological conditions where attachment of muscle
fibers to the basal lamina is impaired. The precise mech-
anism by which LM-111 can promote regeneration inA
24 hours
Figure 5 Myoblast proliferation after treatment with muscle-derived
mMSCs were plated on laminin (LAM) or collagen (COL) and were either e
primary myoblasts treated with conditioned media for 24 hours (A) or 48 h
standard error of the mean of fold change relative to myoblasts treated wi
Lam/No Strain. **P <0.01 versus LAM with n = 6 per group for the 24-hour
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide.healthy adult muscle is not currently known. Interestingly,
the only mRNA in this study that displayed some regula-
tion by mechanical strain was collagen 1α1, which exhib-
ited a strong trend for an interaction (P = 0.050),
increasing on LAM with strain and decreasing on COL
with strain. The upregulation of collagen 1α1 in responseB
48 hours
mesenchymal stem/stromal cell (mMSC) conditioned media.
xposed to mechanical strain or remained unstrained. The quantity of
ours (B) was determined by MTT assay. Data are presented as mean ±
th serum-free media for the same amount of time. *P <0.05 versus
time point and n = 7 per group for the 48-hour time point. MTT,
Figure 6 Hypertrophic signaling in C2C12-derived myotubes exposed to muscle-derived mesenchymal stem/stromal cell (mMSC)
conditioned media. mMSCs were plated on laminin (LAM) or collagen (COL) and were either exposed to mechanical strain or remained
unstrained. C2C12-derived myotubes treated with conditioned media for 3 hours were harvested and analyzed for activation of mammalian target
of rapamycin (mTOR) (A) and p70 (B). Representative images are shown above each respective blot. Data are presented as mean ± standard error
of the mean. AU, arbitrary units.
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remodeling similar to what has been demonstrated with
exercise [51]. The basally elevated levels of collagen 1α1
expression in mMSCs grown on COL are reminiscent of
cellular dysregulation in fibrotic conditions [19,20].
A potential explanation for the decreased expression
of inflammatory and ECM-related genes in mMSCs
plated on collagen is that mMSCs plated on collagen
recognize this collagen-rich environment as a healed
wound. TGF-β1 is well known to promote wound heal-
ing acutely, whereas excess TGF-β1 can lead to fibrosis
[52], potentially via the promotion of mMSC differenti-
ation toward a myofibroblast phenotype [53]. Myofibro-
blasts are derived from a variety of cell types, including
MSCs, and acute activation of myofibroblasts is import-
ant for tissue repair as they are responsible for secreting
ECM proteins that form a new matrix for repaired or re-
modeled tissue [54]. In the present study, mMSCs plated
on COL decreased their level of TGF-β1 expression,
suggesting that their differentiation toward a myofibro-
blast phenotype may have been impaired. These data
suggest a mechanism whereby TGF-β1 is downregulated
on COL inhibiting the myofibroblast phenotype and
ECM remodeling. It is important to note that chronic
activation of myofibroblasts can lead to tissue fibrosis
and contracture [54]. Thus, mMSCs plated on COL may
recognize their environment as one that is already fully
healed [52] and downregulate their expression of various
repair factors, including inflammatory cytokines and
ECM proteins, while plating on LAM may mimic an en-
vironment in the early stages of repair.
The alterations in mMSC gene expression in the pres-
ence of COL and LAM prompted us to investigate the
capacity for the mMSC secretome to differentially im-
pact myoblast activation and myotube growth. In vitro
experiments were conducted to determine the full extentto which the mMSC secretome could impact these
events in muscle. We did not observe any change in
anabolic signaling (mTOR, p70) in myotubes treated
with CM from mMSCs, suggesting that stimulation of
protein synthesis is not the primary mechanism whereby
mMSCs contribute to muscle repair or hypertrophy. On
the other hand, we did observe differential regulation of
myoblast proliferation in CM experiments. CM from
mMSCs strained on LAM increased myoblast quantity
24 hours post-treatment relative to all other conditions.
These differential effects on myoblast proliferation were
seen despite no differences in HGF expression between
mMSCs on LAM or COL with or without strain. HGF is
the ligand for the c-met receptor and initiates satellite
cell activation [55]. Since myoblasts in culture are
already actively proliferating, HGF may not be the pri-
mary paracrine factor underlying this response. The im-
pact of strain on myoblast proliferation was unexpected
given the lack of change in gene expression in response
to strain. However, the delayed increase in FAK phos-
phorylation at 24 hours post-strain in mMSCs exposed
to LAM suggests that strain may have a long-term effect
on intracellular actin remodeling or adhesion or both.
We hypothesize that growth on LAM is a signal to in-
crease the transcription of various growth/inflammatory
factors and that mechanical strain is the stimulus to
allow the release of these factors. Indeed, previous stud-
ies have shown that mechanical strain promotes release
of growth factors from mMSCs [16] and MDSCs [36].
Differential production of paracrine factors in mMSCs
plated on LAM versus COL may explain the upregula-
tion of myoblast quantity at 24 hours when treated with
LAM CM versus the delayed increase to 48 hours in
myoblasts treated with COL CM as the concentration of
paracrine factors in LAM CM may have been higher.
Whether the delay in myoblast expansion observed with
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is reflective of a corresponding time delay in FAK phos-
phorylation is not known.
In humans, NF-κB expression following eccentric con-
traction was recently linked to paracrine factor release,
and NF-κB was localized primarily to pericytes, a popu-
lation of cells similar to mMSCs [10]. Since we observed
decreased inflammatory factor expression in mMSCs
plated on COL in the present study, we examined the
activation of NF-κB in mMSCs on LAM and COL with
or without strain. We did not observe any alterations in
levels of phosphorylated or total NF-κB under the condi-
tions explored in the present investigation, suggesting
that different mechanisms may be responsible for the ef-
fects observed.
A potential limitation of our study is the use of com-
mercially available Flexcell plates pre-coated with lam-
inin and collagen peptide. This model has been used
previously in the literature to examine the effects of dif-
ferent substrates [31] and mechanical strain [12,16,56]
on primary myoblasts and mMSCs. The data presented
here provide the first step in evaluating the mMSC re-
sponse to strain in the context of substrate, yet further
studies are necessary to confirm and expand this infor-
mation. Our lab is currently developing novel methods
that will allow the evaluation of the mMSC response to
strain in the presence of a wide variety of full-length
substrates in the context of stiffness. These studies are
essential to fully understand the role for mMSCs in tis-
sue health and assist in the development of stem cell-
based therapies.
The data presented here demonstrate that MSCs are
responsive to their microenvironment and this may suggest
that injecting MSCs into an inflamed or fibrotic environ-
ment could alter their secretome and impair their capacity
for regeneration. Previous literature would suggest that the
MSC secretome is maintained for at least a short while after
transplantation into an inflamed or fibrotic environment.
MSC co-transplantation with hematopoietic stem cells in a
hematopoietic stem cell transplant promotes hematopoietic
regeneration although donor MSCs are not detected in
recipient bone marrow at late time points following
transplantation [57,58]. In cardiac infarction models, MSCs
promote cardiac remodeling through secretion of para-
crine factors detectable 2 weeks post-transplantation [59]
although the majority of MSCs die within 4 days of trans-
plantation [60]. Together, these studies suggest that MSCs
are rapidly lost following transplantation and this may
represent a protective mechanism that prevents their
secretome from being altered when transplanted into an
inflamed or fibrotic environment. The beneficial effects of
MSC therapy in these models are realized acutely after
MSC transplantation that initiates a local regenerative
response through release of paracrine factors.Conclusions
mMSCs are responsive to their environment and may
participate in the detrimental changes in tissue health in
fibrotic conditions. Growth on collagen 1 inhibits gene
expression and alters the secretion of factors involved in
myoblast proliferation or survival or both. Further stud-
ies should focus on the extent to which MSC precondi-
tioning with laminin or mechanical strain or both can
improve outcomes associated with MSC transplantation
as well as determine the extent to which laminin or
physical activity or both can directly recover endogenous
mMSC function in diseased and aged skeletal muscle.
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